Skip to main content
Boule Diagnostics logo

Boule Diagnostics — Investor Relations & Filings

Ticker · BOUL ISIN · SE0011231158 LEI · 213800IK1TGY858TKZ45 ST Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2013-06-28 Regulatory Filings
Country SE Sweden
Listing ST BOUL

About Boule Diagnostics

https://boule.com/

Boule Diagnostics is a global provider of diagnostic solutions specializing in hematology. The company develops, manufactures, and markets systems and consumables for blood diagnostics, including hematology analyzers, clinical chemistry analyzers, and associated reagents, controls, and calibrators. Its products are tailored for decentralized healthcare settings in both the human and veterinary markets, such as smaller laboratories and clinics. The company aims to enhance global healthcare access by providing high-quality instruments that deliver timely and accurate blood test results.

Recent filings

Filing Released Lang Actions
Boule Diagnostics tecknar avtal med Karolinska Universitetslaboratoriet för kliniskt samarbete vid utveckling av hematologisystem
Regulatory Filings Classification · 1% confidence The document is a press release announcing a strategic agreement between Boule Diagnostics and Karolinska University Laboratory for clinical collaboration in hematology system development. It contains details about the agreement, quotes from the CEO, and standard boilerplate information about the companies involved. Crucially, it ends with a statement about public disclosure requirements ('Informationen i detta pressmeddelande är sådan som Boule Diagnostics AB ska offentliggöra enligt lagen om värdepappersmarknaden...'). This structure strongly indicates a general regulatory announcement or press release that doesn't fit the specific financial report categories (10-K, IR, ER) or specific corporate actions (DIV, CAP, DIRS). Since it is a formal announcement of a business development that needs to be made public according to securities law, and it doesn't fit the other specific categories like M&A (TAR) or Capital Change (SHA), the most appropriate general category for regulatory announcements that don't fit elsewhere is Regulatory Filings (RNS). The document length (3015 chars) is short, but it is the primary announcement itself, not an announcement *of* another report, so RPA is less fitting than RNS for this type of business update.
2013-06-28 Swedish
Kommuniké från Boule Diagnostics ABs årsstämma den 23 april 2013
AGM Information Classification · 1% confidence The document is explicitly titled 'Kommuniké från Boule Diagnostics ABs årsstämma den 23 april 2013' (Communiqué from Boule Diagnostics AB's Annual General Meeting on April 23, 2013). It details decisions made regarding the approval of financial statements, dividend declaration, granting discharge to the board, election of board members, and approval of remuneration and incentive programs. These are all core activities of an Annual General Meeting (AGM). Although it is a communiqué summarizing the event, the content directly relates to the AGM proceedings and outcomes, making 'AGM Information' (AGM-R) the most appropriate classification, as it represents materials shared during or immediately following the AGM.
2013-04-24 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for Boule Diagnostics AB for the period January-March 2013. It contains comprehensive financial statements, including income statements, balance sheets, cash flow analysis, and management commentary on business performance, regional sales, and financial goals. It is not an announcement of a report, but the report itself, and it covers a period shorter than a full fiscal year. Q1 2013
2013-04-23 Swedish
Annual Report 2012
Annual Report Classification · 1% confidence The document is titled 'Boule Diagnostics årsredovisning 2012' (Annual Report 2012). It contains comprehensive financial statements, management reports, notes to the financial statements, and an auditor's report. It covers the full fiscal year 2012 and provides detailed business performance analysis, making it a standard Annual Report. FY 2012
2013-04-02 Swedish
Boule Diagnostics publicerar årsredovisningen för 2012
Report Publication Announcement Classification · 1% confidence The document text is very short (925 characters) and its primary function is to announce that the full annual report ('årsredovisningen') for 2012 has been published on the company's website ('har idag publicerat den fullständiga årsredovisningen'). This fits the 'MENU VS MEAL' rule, indicating it is an announcement about a report, not the report itself. The most appropriate category for announcing the publication of a report is Report Publication Announcement (RPA). The Swedish term 'årsredovisningen' translates to 'annual report', but since this is just the announcement, RPA is selected over 10-K.
2013-04-02 Swedish
KALLELSE TILL ÅRSSTÄMMA I BOULE DIAGNOSTICS AB
AGM Information Classification · 1% confidence The document is titled "KALLELSE TILL ÅRSSTÄMMA I BOULE DIAGNOSTICS AB" which translates to 'NOTICE OF ANNUAL GENERAL MEETING IN BOULE DIAGNOSTICS AB'. The text details the date, time, location, registration procedures, agenda items (including election of board members, approval of financial statements, dividend proposals, and remuneration guidelines), and specific proposals for shareholder votes. This content is characteristic of a formal notice and agenda for an Annual General Meeting (AGM). Although it contains elements that might appear in other reports (like financial results discussion under agenda points 7 and 8), the primary purpose and structure are that of the AGM notice itself. Therefore, the most appropriate classification is AGM Information (AGM-R).
2013-03-18 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.